Safe and Affordable Drugs from Canada Act of 2019
- Last Action
- 1/25/2019
Actions
- 2019-01-25Referred to the Subcommittee on Health.
- 2019-01-10Referred to the House Committee on Energy and Commerce.
- 2019-01-10Introduced in House
- 2019-01-10Introduced in House
CRS Summary
As of 2019-01-10 (00)
Safe and Affordable Drugs from Canada Act of 2019
This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA.
Under the bill, certain drugs may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
Cosponsors (15)
- Jaime Herrera Beutler (R-WA)
- Jared Golden (D-ME)
- LLOYD DOGGETT (D-TX)
- Steve Cohen (D-TN)
- Daniel Lipinski (D-IL)
- Ed Case (D-HI)
- John Garamendi (D-CA)
- Peter Welch (D-VT)
- Max Rose (D-NY)
- Angie Craig (D-MN)
- TIM RYAN (D-OH)
- Ro Khanna (D-CA)
- Elissa Slotkin (D-MI)
- David Joyce (R-OH)
- Thomas Tiffany (R-WI)
Subjects
- Administrative law and regulatory procedures
- Canada
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Prescription drugs
- Trade restrictions
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.